Anu Thummala
Impact in
- Oncology top 2%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
-
- Advanced Breast Cancer Therapies
Papers in
-
- Advanced Breast Cancer Therapies 11
- Oncology 11
- HER2/EGFR in Cancer Research 6
- Cancer Treatment and Pharmacology 3
- Cancer-related Molecular Pathways 3
- Colorectal Cancer Surgical Treatments 1
- Colorectal Cancer Treatments and Studies 1
- Co-authors
- Richard S. Finn (8 shared papers)Dennis J. Slamon (8 shared papers)Xin Huang (8 shared papers)Tamás Pintér (5 shared papers)Ravindranath Patel (4 shared papers)Johannes Ettl (6 shared papers)Yaroslav Shparyk (5 shared papers)Marcus Schmidt (6 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Cancer Research (2 papers)The Lancet Oncology (2 papers)Clinical Cancer Research (1 paper)Breast Cancer Research and Treatment (1 paper)
- Partner nations
- United StatesHungaryGermany
In The Last Decade
Anu Thummala
12 papers receiving 1.7k citations
Anu Thummala's Hit Papers
Peers
Comparison fields: 5 of 65
- Oncology 1.4k
- Pulmonary and Respiratory Medicine 1.4k
- Cancer Research 547
- Genetics 330
- Genetics 120
Countries citing papers authored by Anu Thummala
This map shows the geographic impact of Anu Thummala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anu Thummala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anu Thummala more than expected).
Fields of papers citing papers by Anu Thummala
This network shows the impact of papers produced by Anu Thummala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anu Thummala. The network helps show where Anu Thummala may publish in the future.
Co-authors
The 25 scholars most cited alongside Anu Thummala, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study Hit paper breakdown → | 2014 | 1412 |
| 2 | 2020 | 111 | |
| 3 | 2019 | 86 | |
| 4 | 2017 | 53 | |
| 5 | 2014 | 37 | |
| 6 | 2021 | 28 | |
| 7 | 2021 | 6 | |
| 8 | 2015 | 6 | |
| 9 | 2015 | 4 | |
| 10 | 2015 | 3 | |
| 11 | 2014 | 3 | |
| 12 | 2015 | 1 |
About Anu Thummala
Anu Thummala is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Genetics and Surgery, having authored 12 papers that have together received 1.8k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (11 papers), HER2/EGFR in Cancer Research (6 papers), Cancer Treatment and Pharmacology (3 papers), Breast Cancer Treatment Studies (3 papers), Cancer-related Molecular Pathways (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Colorectal Cancer Surgical Treatments (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Oncology (1.4k citations), Pulmonary and Respiratory Medicine (1.4k citations), Cancer Research (547 citations), Genetics (330 citations) and Genetics (120 citations). Anu Thummala has collaborated with scholars based in United States, Hungary and Germany. Frequent co-authors include Richard S. Finn, Dennis J. Slamon, Xin Huang, Tamás Pintér, Ravindranath Patel, Johannes Ettl, Yaroslav Shparyk, Marcus Schmidt, Igor Bondarenko and Katalin Boér. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, The Lancet Oncology, Clinical Cancer Research and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.